JNK1 as a molecular target to limit cellular mortality under hypoxia

Molecular Pharmaceutics

Volumn 3, Issue 4, 2006, Pages 424-430

  Betigeri, Seema ^a   Pakunlu, Refika I ^a   Wang, Yang ^a   Khandare, Jayant J ^a   Minko, Tamara ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antisense oligonucleotides; Apoptosis; Hypoxia; Intracellular localization; Jun N terminal kinase 1; Liposomal delivery; siRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

APOPTOSIS; BASE SEQUENCE; CELL HYPOXIA; CELL LINE; GENE EXPRESSION; HUMANS; LIPOSOMES; MITOGEN-ACTIVATED PROTEIN KINASE 8; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 33748455631     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060014x     Document Type: Article

References (20)

1. Minko, T.; Wang, Y.; Pozharov, V. Remediation of cellular hypoxic damage by pharmacological agents. Curr. Pharm. Des. 2005, 11, 3185-3199.
2. Minko, T.; Stefanov, A.; Pozharov, V. Lung hypoxia: Antioxidant and antiapoptotic effects of liposomal α-tocopherol. J. Appl. Physiol. 2002, 93, 1550-1560.
3. Hellwig-Burgel, T.; Stiehl, D. P.; Wagner, A. E.; Metzen, E.; Jelkmann, W. Hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J. Interferon Cytokine Res. 2005, 25, 297-310.
4. Wang, Y.; Pakunlu, R. I.; Tsao, W.; Pozharov, V.; Minko, T. Bimodal effect of hypoxia in cancer: The role of hypoxia inducible factor in apoptosis. Mol. Pharm. 2004, 1, 156-165.
5. Wang, Y.; Minko, T. A novel cancer therapy: Combined liposomal hypoxia inducible factor Ia antisense oligonucleotides and an anticancer drug. Biochem. Pharmacol. 2004, 68, 2031-2042.
6. Johnson, G. L.; Dohlman, H. G.; Graves, L. M. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr. Opin. Chem. Biol. 2005, 9, 325-331.
7. Bennett, B. L.; Sasaki, D. T.; Murray, B. W.; O'Leary, E. C.; Sakata, S. T.; Xu, W.; Leisten, J. C.; Motiwala, A.; Pierce, S.; Satoh, Y.; Bhagwat, S. S.; Manning, A. M.; Anderson, D. W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 13681-13686.
8. Chihab, R.; Ferry, C.; Koziel, V.; Monin, P.; Daval, J. L. Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons. Brain Res. Mol. Brain Res. 1998, 63, 105-120.
9. Zhou, G.; Golden, T.; Aragon, I. V.; Honkanen, R. E. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J. Biol. Chem. 2004, 279, 46595-46605.
10. Derijard, B.; Hibi, M.; Wu, I. H.; Barrett, T.; Su, B.; Deng, T.; Karin, M.; Davis, R. J. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76, 1025-1037.
11. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 1995, 270, 16483-16486.
12. Crenesse, D.; Laurens, M.; Heurteaux, C.; Cursio, R.; Saint-Paul, M. C.; Schmid-Alliana, A.; Gugenheim, J. Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment. Eur. J. Pharmacol. 2003, 473, 177-184.
13. Garay, M.; Gaarde, W.; Monia, B. P.; Nero, P.; Cioffi, C. L. Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells. Biochem. Pharmacol. 2000, 59, 1033-1043.
14. Hreniuk, D.; Garay, M.; Gaarde, W.; Monia, B. P.; McKay, R. A.; Cioffi, C. L. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol. Pharmacol. 2001, 59, 867-874.
15. Rapisarda, A.; Uranchimeg, B.; Scudiero, D. A.; Selby, M.; Sausville, E. A.; Shoemaker, R. H.; Melillo, G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 2002, 62, 4316-4324.
16. Pakunlu, R. I.; Cook, T. J.; Minko, T. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin. Pharm. Res. 2003, 20, 351-359.
17. Pakunlu, R. I.; Wang, Y.; Tsao, W.; Pozharov, V.; Cook, T. J.; Minko, T. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: Novel multicomponent delivery system. Cancer Res. 2004, 64, 6214-6224.
18. Pakunlu, R. I.; Wang, Y.; Saad, M.; Khandare, J. J.; Minko, T. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J. Controlled Release 2006. in press.
19. Dharap, S. S.; Wang, Y.; Chandna, P.; Khandare, J. J.; Qiu, B.; Gunaseelan, S.; Stein, S.; Farmanfarmaian, A.; Minko, T. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 12962-12967.
20. Minko, T.; Kopeckova, P.; Pozharov, V.; Kopecek, J. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J. Controlled Release 1998, 54, 223-233.